NEW YORK, N.Y. (April 24, 2014) – A new study from investigators with the Autism Genome Project, the world’s largest research project on identifying genes associated with risk for autism, has found that the comprehensive use of copy number variant (CNV) genetic testing offers an important tool in individualized diagnosis and treatment of autism.
Funded primarily by Autism Speaks, the world’s leading autism science and advocacy organization, the Autism Genome Project involved more than 50 research centers in 11 countries. The report, published today in the American Journal of Human Genetics, delivers on the 10-year project’s objective to provide practical methods for earlier diagnosis and personalized treatment of autism.
Autism Awareness: Clinic Working on Test for Early Detection
CLEVELAND– A leading healthcare facility in Northeast Ohio is working on new autism-related research that could change millions of lives.
Doctors and researchers at the Cleveland Clinic are working to develop a new urine test. It could help detect autism before symptoms typically show up in kids around age two.
“It’s not months. It’s not weeks. It’s gonna be years,” said Dr. Charis Eng from the Genomic Medicine Institute. She’s working on the urine test that is still in the early stages.